Target Name: MIR6717
NCBI ID: G102465428
Other Name(s): MicroRNA 6717 | hsa-miR-6717-5p | hsa-mir-6717 | microRNA 6717

MicroRNA 6717: A Potential Drug Target and Biomarker

MicroRNA 6717 (MIR6717) is a non-coding RNA molecule that has been identified as a potential drug target and biomarker for various diseases, including cancer. MIR6717 is a key regulator of gene expression in various cell types and is involved in the regulation of cell cycle progression, apoptosis, and inflammation.

The discovery of MIR6717 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. MIR6717 has been shown to play a role in the regulation of cell cycle progression, which is the process by which cells grow, divide, and replicate their genetic material. MIR6717 is known to regulate the activity of the cyclin D1 gene, which encodes the protein cyclin D1.

Cyclin D1 is a key regulator of the cell cycle and is involved in the regulation of mitosis, meiosis, and the G1/G2 phase of the cell cycle. MIR6717 has been shown to play a role in the regulation of cyclin D1 activity by binding to its downstream consensus binding site, which is located on the alpha-helix of the cyclin D1 protein.

MIR6717 has also been shown to regulate the apoptosis, which is the process by which cells undergo programmed cell death. MIR6717 has been shown to play a role in the regulation of apoptosis by binding to the B-cell lymphoma 1 (Bcl-1) gene, which encodes a protein that can induce apoptosis in cancer cells.

In addition to its role in cell cycle progression and apoptosis, MIR6717 has also been shown to play a role in the regulation of inflammation. MIR6717 has been shown to regulate the activity of the nuclear factor kappa B (NF-kappa-B) gene, which encodes a protein that can activate the NF-kappa-B signaling pathway. NF-kappa-B signaling is involved in the regulation of inflammation and has been implicated in the development of various diseases, including cancer.

MIR6717 has also been shown to play a role in the regulation of stem cell maintenance and proliferation. MIR6717 has been shown to regulate the activity of the Runx1a gene, which encodes a protein that can promote the self-renewal and survival of stem cells.

The identification of MIR6717 as a potential drug target and biomarker has significant implications for the development of new treatments for various diseases. MIR6717 is a key regulator of gene expression in various cell types and is involved in the regulation of cell cycle progression, apoptosis, and inflammation. Further research is needed to fully understand the role of MIR6717 in the regulation of these processes and to develop new treatments based on this understanding.

Protein Name: MicroRNA 6717

More Common Targets

MIR6718 | MIR6719 | MIR6720 | MIR6721 | MIR6722 | MIR6724-1 | MIR6726 | MIR6727 | MIR6728 | MIR6729 | MIR6730 | MIR6731 | MIR6732 | MIR6733 | MIR6734 | MIR6735 | MIR6736 | MIR6737 | MIR6738 | MIR6739 | MIR6740 | MIR6741 | MIR6742 | MIR6743 | MIR6744 | MIR6746 | MIR6747 | MIR6748 | MIR6749 | MIR675 | MIR6750 | MIR6751 | MIR6752 | MIR6753 | MIR6754 | MIR6755 | MIR6756 | MIR6757 | MIR6758 | MIR6759 | MIR676 | MIR6760 | MIR6761 | MIR6762 | MIR6763 | MIR6764 | MIR6765 | MIR6766 | MIR6767 | MIR6768 | MIR6769A | MIR6769B | MIR6770-1 | MIR6770-2 | MIR6770-3 | MIR6771 | MIR6772 | MIR6773 | MIR6774 | MIR6775 | MIR6776 | MIR6777 | MIR6778 | MIR6779 | MIR6780A | MIR6780B | MIR6781 | MIR6782 | MIR6783 | MIR6784 | MIR6785 | MIR6786 | MIR6787 | MIR6788 | MIR6789 | MIR6790 | MIR6791 | MIR6792 | MIR6793 | MIR6794 | MIR6795 | MIR6796 | MIR6797 | MIR6798 | MIR6799 | MIR6800 | MIR6801 | MIR6802 | MIR6803 | MIR6804 | MIR6805 | MIR6806 | MIR6807 | MIR6808 | MIR6809 | MIR6810 | MIR6811 | MIR6812 | MIR6813 | MIR6814